{"disease":{"id":"skull-base-cancer","name":"skull base cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05947149","title":"HRQoL in Patients With Solid Tumors Treated With Hadrontherapy","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"CNAO National Center of Oncological Hadrontherapy","has_results":false},{"nct_id":"NCT07145931","title":"Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}